RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Feature ArticlesFeature Articles

    Regulatory Quality Compliance Programs for Drugs and Biologics in the US and Canada

    An overview of compliance activities applicable for drugs and biologics in the US and Canada, as well as useful tools to strengthen quality compliance programs. Responsibility for the maintenance and enhancement of public health and safety is shared by government, industry, consumers, healthcare professionals and their respective associations. Regulated parties marketing drugs and biologics have primary responsibility to ensure the safety and efficacy of any product t...